Tuberous Sclerosis Complex Kidney Lesion Pathogenesis: A Developmental Perspective

J Am Soc Nephrol. 2023 Jul 1;34(7):1135-1149. doi: 10.1681/ASN.0000000000000146. Epub 2023 Apr 15.

Abstract

The phenotypic diversity of tuberous sclerosis complex (TSC) kidney pathology is enigmatic. Despite a well-established monogenic etiology, an incomplete understanding of lesion pathogenesis persists. In this review, we explore the question: How do TSC kidney lesions arise? We appraise literature findings in the context of mutational timing and cell-of-origin. Through a developmental lens, we integrate the critical results from clinical studies, human specimens, and genetic animal models. We also review novel insights gleaned from emerging organoid and single-cell sequencing technologies. We present a new model of pathogenesis which posits a phenotypic continuum, whereby lesions arise by mutagenesis during development from variably timed second-hit events. This model can serve as a conceptual framework for testing hypotheses of TSC lesion pathogenesis, both in the kidney and in other affected tissues.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Humans
  • Kidney / pathology
  • Tuberous Sclerosis Complex 1 Protein / genetics
  • Tuberous Sclerosis Complex 2 Protein
  • Tuberous Sclerosis* / genetics
  • Tuberous Sclerosis* / pathology
  • Tumor Suppressor Proteins* / genetics

Substances

  • Tumor Suppressor Proteins
  • Tuberous Sclerosis Complex 2 Protein
  • Tuberous Sclerosis Complex 1 Protein

Grants and funding